FLUIDDA is the world leader in the field of Functional Respiratory Imaging (FRI) research and development. The company’s proprietary FRI technology offers pharmaceutical companies and healthcare providers a unique entry point into personalized medicine for patients suffering from respiratory diseases and sleep-related breathing disorders. Implementation of FRI in the clinical practice creates significant added value to the current healthcare standard in the respiratory field.
Some facts …
FLUIDDA was founded in 2005. Its Head Office is located in Kontich, Belgium, with subsidiaries in India and the US and Portugal. The executive officers are graduates of engineering and aerospace engineering programs focusing on Computational Fluid Dynamics (CFD), a discipline used in the design of aircraft wings. At FLUIDDA, this expertise is applied to the diagnosis and monitoring of respiratory diseases.
Flow simulations are combined with CT scans to provide a unique sensitive tool for phenotyping patients and monitoring the efficacy of novel respiratory drugs.
FLUIDDA developed its novel FRI technology in house and is now expanding its commercial portfolio.